Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers

Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire

(2009) G. Bioley et al.   CLINICAL CANCER RESEARCH

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Reassessing the role of HLA-DRB3 T-cell responses: Evidence for significant expression and complementary antigen presentation

(2009) Rosa Faner et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor ROR t

(2009) M. Ayyoub et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Use of MHC class II tetramers to investigate CD4+T cell responses: Problems and solutions

(2008) Virginia Cecconi et al.   CYTOMETRY PART A

Class II major histocompatibility complex tetramer staining: progress, problems, and prospects

(2008) Sabrina S. Vollers et al.   IMMUNOLOGY

The structure of HLA-DR52c: Comparison to other HLA-DRB3 alleles

(2008) S. Dai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA